Clinical Trial

Induction Chemotherapy for Locally Advanced Esophageal Cancer

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Evaluate mFOLFOX6 (5-Fluorouracil, Leucovorin and Oxaliplatin) chemotherapy as induction treatment prior to standard neoadjuvant chemoradiation to decrease the rate of distant recurrence among patients with locally advanced esophageal cancer.
Protocol Amendment History 11 amendments
This ClinicalTrials.gov record has been amended 11 times since 2017-04-05; most recent amendment 2025-09-05.
Status change: Recruiting → Active, Not Recruiting 2021-10-12
Status change: Not Yet Recruiting → Recruiting 2017-06-21
Trial Details
NCT Number NCT03110926
Lead Sponsor University of Rochester
Conditions Esophageal Carcinoma
Enrollment 40 participants
Start Date 2017-06-19
Primary Completion 2027-05-31 (estimated)
Study Completion 2027-05-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-12